138 related articles for article (PubMed ID: 11302334)
1. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas.
Raithatha SA; Muzik H; Muzik H; Rewcastle NB; Johnston RN; Edwards DR; Forsyth PA
Neuro Oncol; 2000 Jul; 2(3):145-50. PubMed ID: 11302334
[TBL] [Abstract][Full Text] [Related]
2. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
3. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
5. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Vince GH; Wagner S; Pietsch T; Klein R; Goldbrunner RH; Roosen K; Tonn JC
Int J Dev Neurosci; 1999; 17(5-6):437-45. PubMed ID: 10571406
[TBL] [Abstract][Full Text] [Related]
7. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
Komatsu K; Nakanishi Y; Nemoto N; Hori T; Sawada T; Kobayashi M
Brain Tumor Pathol; 2004; 21(3):105-12. PubMed ID: 15696970
[TBL] [Abstract][Full Text] [Related]
8. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
10. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
11. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.
Mendes O; Kim HT; Stoica G
Clin Exp Metastasis; 2005; 22(3):237-46. PubMed ID: 16158251
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
[TBL] [Abstract][Full Text] [Related]
13. Aberrant activation of Hedgehog/Gli1 pathway on angiogenesis in gliomas.
Cui D; Chen X; Yin J; Wang W; Lou M; Gu S
Neurol India; 2012; 60(6):589-96. PubMed ID: 23287320
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
Groft LL; Muzik H; Rewcastle NB; Johnston RN; Knäuper V; Lafleur MA; Forsyth PA; Edwards DR
Br J Cancer; 2001 Jul; 85(1):55-63. PubMed ID: 11437402
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas.
Brell M; Ibáñez J; Felpete A; Burguera B; Frontera M; Couce ME
Brain Tumor Pathol; 2011 Apr; 28(2):137-44. PubMed ID: 21331614
[TBL] [Abstract][Full Text] [Related]
19. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of glioma cell migration and invasion.
Wild-Bode C; Weller M; Wick W
J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
